biologic

Albutein

Albumin (Human)

Loss of exclusivityAugust 1990projected — 12-year biologic exclusivity estimate
CompanyGrifols Biologicals LLC

Drug detail

Brand nameAlbutein
Active ingredientAlbumin (Human)
Strength20G/100ML
Dosage formInjection
RouteIntravenous
ModalityBiologic
FDA approvalAugust 1978
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Albutein patent cliff — loss of exclusivity August 1990 | CliffBio